| Aug 13 |
XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities
|
| Aug 8 |
ITeos Therapeutics, Inc. (ITOS) Reports Q2 Loss, Tops Revenue Estimates
|
| Jul 18 |
Xoma (XOMA) Surges 6.4%: Is This an Indication of Further Gains?
|
| Jun 29 |
XOMA Corporation: A Hold Rating With Steady Income From Preferred Shares
|
| Jun 28 |
XOMA Corporation's (NASDAQ:XOMA) institutional investors lost 11% last week but have benefitted from longer-term gains
|
| Jun 21 |
Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?
|
| Jun 20 |
XOMA Declares Quarterly Preferred Stock Dividends
|
| Jun 12 |
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
|
| Jun 12 |
3 Crazy Good Stocks to Buy With $500 Right Now
|
| Jun 4 |
ImmunityBio, LadRx end licensing deal for cancer drug
|
